WALGREENS BOOTS ALLIANCE INC (NASDAQ: WBA)

WALGREENS BOOTS ALLIANCE INC

NASDAQ: WBA (Walgreens Boots Alliance, Inc.)

Last update: 17 Jan, 7:55PM

12.52

-0.41 (-3.17%)

Add to watchlist

Previous Close	12.93
Open	13.03
Volume	29,532,005
Avg. Volume (3M)	23,681,750
Market Cap	11,173,498,880

Price / Earnings (Forward)	6.08
Price / Sales	0.050
Price / Book	0.770

52 Weeks Range	8.08 (-35%) — 23.77 (89%)
Earnings Date	26 Mar 2025 - 31 Mar 2025
TTM Dividend Yield	7.99%

Market Trend

		Short Term	Medium Term
Industry	Pharmaceutical Retailers (US)	Mixed	Mixed
	Pharmaceutical Retailers (Global)	Mixed	Mixed
Stock	Walgreens Boots Alliance, Inc.	Bullish	Bearish

AIStockmoo Score

-1.3

Analyst Consensus	-2.5
Insider Activity	NA
Price Volatility	-2.0
Technical Moving Averages	-1.0
Technical Oscillators	0.5
Average	-1.25

Similar Stocks

Stock	Market Cap	DY	P/E (TTM)	P/B
WBA	11 B	7.99%	-	0.770
PETS	99 M	-	-	1.02
SCNX	37 M	225.65%	-	0.390
MEDS	13 M	134.56%	-	0.900
CJJD	12 M	-	-	0.430
HITI	246 M	-	-	2.58

Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
Sector	Healthcare
Industry	Pharmaceutical Retailers
Investment Style	Small Value
% Held by Insiders	17.49%
% Held by Institutions	61.83%

52 Weeks Range	8.08 (-35%) — 23.77 (89%)
Price Target Range	8.50 (-32%) — 12.00 (-4%)
High	12.00 (RBC Capital, -4.15%)	Hold
	12.00 (Truist Securities, -4.15%)	Hold
	12.00 (Evercore ISI Group, -4.15%)	Hold
Median	12.00 (-4.15%)
Low	8.50 (B of A Securities, -32.11%)	Sell
Average	11.13 (-11.10%)
Total	3 Hold, 1 Sell
Avg. Price @ Call	11.65

Firm	Date	Target Price	Call	Price @ Call
Truist Securities	31 Jan 2025	12.00 (-4.15%)	Hold	10.28
Truist Securities	16 Jan 2025	13.00 (3.83%)	Hold	12.93
RBC Capital	15 Jan 2025	12.00 (-4.15%)	Hold	12.53
RBC Capital	04 Dec 2024	9.00 (-28.12%)	Hold	8.74
B of A Securities	13 Jan 2025	8.50 (-32.11%)	Sell	11.90
Evercore ISI Group	13 Jan 2025	12.00 (-4.15%)	Hold	11.90

No data within this time range.

Date	Type	Details
04 Feb 2025	Announcement	Walgreens Marks One-Year Anniversary of Deans Advisory Council, Driving Progress in Addressing Pharmacy Industry Challenges
30 Jan 2025	Announcement	Walgreens Boots Alliance Suspends Quarterly Dividend as Company Continues Disciplined Execution Against Strategic Priorities
23 Jan 2025	CNBC	Store closures hit highest level since pandemic — see who is shutting down the most locations
10 Jan 2025	Announcement	Walgreens Boots Alliance Reports Fiscal 2025 First Quarter Results
10 Jan 2025	CNBC	Walgreens shares soar 27% on big earnings beat, as drugstore chain cuts costs
02 Jan 2025	Announcement	Walgreens Boots Alliance Adjusts Fiscal 2025 First Quarter Earnings Announcement to be Held on January 10
18 Dec 2024	Announcement	DELETED: CaringBridge and Walgreens Announce $50,000 Donation Match on www.CaringBridge.org to Support Family Caregivers
13 Dec 2024	Announcement	Walgreens Launches Inaugural Patient Advisory Board to Advance Access and Representation in Clinical Research
12 Dec 2024	Announcement	Nearly a Third of Americans Worry About Missing a Holiday Event Due to Illness
10 Dec 2024	Announcement	Soda Health Adds Walgreens to Network of Integrated Retailers, Serving More than 100 Million Medicare Advantage and Medicaid Members
06 Dec 2024	Announcement	Walgreens Boots Alliance Schedules Fiscal 2025 First Quarter Earnings Announcement for January 9
29 Nov 2024	Announcement	Walgreens Boots Alliance Provides Notice of Pending and Proposed Settlement of Shareholder Derivative Action
07 Nov 2024	CNBC	FDA proposes ending use of decongestant found in many cold, allergy medicines
06 Nov 2024	CNBC	E.l.f. shares soar as cosmetics retailer raises guidance after posting 40% sales gain
Show more

TTM Dividend Yield	7.99%
5Y Average Dividend Yield	6.29%
Payout Ratio	290.91%
Expected Next Dividend Payment	Mar 2025

Ex Date	Announcement Date	Payment Date	Details
18 Nov 2024	24 Oct 2024	12 Dec 2024	0.25 Cash
21 Aug 2024	10 Jul 2024	12 Sep 2024	0.25 Cash
20 May 2024	25 Apr 2024	12 Jun 2024	0.25 Cash
16 Feb 2024	03 Jan 2024	12 Mar 2024	0.25 Cash
13 Nov 2023	26 Oct 2023	12 Dec 2023	0.48 Cash
18 Aug 2023	12 Jul 2023	12 Sep 2023	0.48 Cash
18 May 2023	20 Apr 2023	12 Jun 2023	0.48 Cash
15 Feb 2023	26 Jan 2023	10 Mar 2023	0.48 Cash
14 Nov 2022	27 Oct 2022	12 Dec 2022	0.48 Cash
18 Aug 2022	13 Jul 2022	09 Sep 2022	0.48 Cash
19 May 2022	28 Apr 2022	10 Jun 2022	0.4775 Cash
17 Feb 2022	27 Jan 2022	11 Mar 2022	0.4775 Cash
12 Nov 2021	20 Oct 2021	10 Dec 2021	0.4775 Cash
19 Aug 2021	14 Jul 2021	10 Sep 2021	0.4775 Cash
20 May 2021	22 Apr 2021	11 Jun 2021	0.4675 Cash
18 Feb 2021	28 Jan 2021	12 Mar 2021	0.4675 Cash
18 Nov 2020	29 Oct 2020	11 Dec 2020	0.4675 Cash
18 Aug 2020	08 Jul 2020	11 Sep 2020	0.4675 Cash
19 May 2020	22 Apr 2020	12 Jun 2020	0.4575 Cash
18 Feb 2020	30 Jan 2020	12 Mar 2020	0.4575 Cash
15 Nov 2019	23 Oct 2019	12 Dec 2019	0.4575 Cash
19 Aug 2019	10 Jul 2019	12 Sep 2019	0.4575 Cash
17 May 2019	18 Apr 2019	12 Jun 2019	0.44 Cash
14 Feb 2019	25 Jan 2019	12 Mar 2019	0.44 Cash
08 Nov 2018	24 Oct 2018	12 Dec 2018	0.44 Cash
17 Aug 2018	28 Jun 2018	12 Sep 2018	0.44 Cash
17 May 2018	11 Apr 2018	12 Jun 2018	0.4 Cash
14 Feb 2018	18 Jan 2018	12 Mar 2018	0.4 Cash
10 Nov 2017	24 Oct 2017	12 Dec 2017	0.4 Cash
16 Aug 2017	12 Jul 2017	12 Sep 2017	0.4 Cash
16 May 2017	20 Apr 2017	12 Jun 2017	0.375 Cash
13 Feb 2017	26 Jan 2017	10 Mar 2017	0.375 Cash
15 Nov 2016	12 Oct 2016	12 Dec 2016	0.375 Cash
17 Aug 2016	13 Jul 2016	12 Sep 2016	0.375 Cash
16 May 2016	12 Apr 2016	10 Jun 2016	0.36 Cash
16 Feb 2016	28 Jan 2016	11 Mar 2016	0.36 Cash
12 Nov 2015	14 Oct 2015	11 Dec 2015	0.36 Cash
17 Aug 2015	08 Jul 2015	11 Sep 2015	0.36 Cash
19 May 2015	08 Apr 2015	12 Jun 2015	0.3375 Cash
13 Feb 2015	15 Jan 2015	12 Mar 2015	0.3375 Cash
13 Nov 2014	08 Oct 2014	12 Dec 2014	0.3375 Cash
19 Aug 2014	05 Aug 2014	12 Sep 2014	0.3375 Cash
19 May 2014	09 Apr 2014	12 Jun 2014	0.315 Cash
13 Feb 2014	09 Jan 2014	12 Mar 2014	0.315 Cash
14 Nov 2013	09 Oct 2013	12 Dec 2013	0.315 Cash
16 Aug 2013	10 Jul 2013	12 Sep 2013	0.315 Cash
13 Feb 2013	10 Jan 2013	12 Mar 2013	0.275 Cash
07 Nov 2012	10 Oct 2012	12 Dec 2012	0.275 Cash
15 Aug 2012	19 Jun 2012	12 Sep 2012	0.275 Cash
17 May 2012	09 Apr 2012	12 Jun 2012	0.225 Cash
17 Aug 2011	13 Jul 2011	12 Sep 2011	0.225 Cash
17 Aug 2010	14 Jul 2010	11 Sep 2010	0.175 Cash
12 Nov 2009	15 Oct 2009	12 Dec 2009	0.1375 Cash
18 Aug 2008	09 Jul 2008	12 Sep 2008	0.1125 Cash
16 Aug 2007	11 Jul 2007	12 Sep 2007	0.095 Cash
16 May 2007	10 Apr 2007	12 Jun 2007	0.0775 Cash
09 Nov 2000	11 Oct 2000	12 Dec 2000	0.035 Cash
16 Aug 2000	01 Jun 2000	15 Sep 2000	0.0337 Cash
Show more

Annual Dividend Yield

Year	Annual Dividend ($)	Frequency/Year	Yield %
2024	1.00	4	10.72
2023	1.92	4	7.35
2022	1.92	4	5.13
2021	1.89	4	3.62
2020	1.85	4	4.64
2019	1.80	4	3.04
2018	1.68	4	2.46
2017	1.55	4	2.13
2016	1.47	4	1.78
2015	1.40	4	1.64
2014	1.31	4	1.71
2013	0.905	3	1.58
2012	0.775	3	2.09
2011	0.225	1	0.68
2010	0.175	1	0.45
2009	0.138	1	0.37
2008	0.113	1	0.46
2007	0.173	2	0.45
2000	0.069	2	0.16
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

Realized Profit	-
Unrealized Profit	-
Dividend Received 2025	-
Total Profit	-
Avg. Return	-
Quantity (Buy)	-
Avg. Price (Buy)	-
Quantity (Sold)	-
Avg. Price (Sold)	-

No stocks matching your criteria

Profit Margin	-5.85%
Operating Margin (TTM)	2.35%
Diluted EPS (TTM)	-10.01
Quarterly Revenue Growth (YOY)	6.00%
Quarterly Earnings Growth (YOY)	191.50%

Total Debt/Equity (MRQ)	277.90%
Current Ratio (MRQ)	0.680
Operating Cash Flow (TTM)	1.02 B
Levered Free Cash Flow (TTM)	2.73 B

Return on Assets (TTM)	0.59%
Return on Equity (TTM)	-75.97%

Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)